Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mechoulam

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
The Journal of Pharmacy and Pharmacology|October 10, 2009
Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trialsArieh Moussaieff, Raphael Mechoulam
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2006
Multiple sclerosis may disrupt endocannabinoid brain protection mechanismEsther Shohami, Raphael Mechoulam
Current Drug Targets. CNS and Neurological Disorders|December 27, 2005
Cannabinoids: between neuroprotection and neurotoxicityYosef Sarne, Raphael Mechoulam
Trends in Pharmacological Sciences|June 26, 2003
Cannabis and alcohol--a close friendshipRaphael Mechoulam, Linda Parker
Current Medicinal Chemistry|February 20, 2010
Novel natural and synthetic ligands of the endocannabinoid systemLumír O Hanus, Raphael Mechoulam
Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society|October 7, 2003
Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in ratsLinda A Parker, Raphael Mechoulam
Dialogues in Clinical Neuroscience|February 22, 2008
Cannabinoids in health and diseaseNatalya M Kogan, Raphael Mechoulam
Annual Review of Psychology|July 19, 2012
The endocannabinoid system and the brainRaphael Mechoulam, Linda A Parker
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2005
Toward an anandamide transporterRaphael Mechoulam, Dale G Deutsch
Pharmacology & Therapeutics|August 17, 2002
Tetrahydrocannabinol and endocannabinoids in feeding and appetiteElliot M Berry, Raphael Mechoulam
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Pharmacy and Pharmacology|October 10, 2009
Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trialsArieh Moussaieff, Raphael Mechoulam
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2006
Multiple sclerosis may disrupt endocannabinoid brain protection mechanismEsther Shohami, Raphael Mechoulam
Current Drug Targets. CNS and Neurological Disorders|December 27, 2005
Cannabinoids: between neuroprotection and neurotoxicityYosef Sarne, Raphael Mechoulam
Trends in Pharmacological Sciences|June 26, 2003
Cannabis and alcohol--a close friendshipRaphael Mechoulam, Linda Parker
Current Medicinal Chemistry|February 20, 2010
Novel natural and synthetic ligands of the endocannabinoid systemLumír O Hanus, Raphael Mechoulam
Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society|October 7, 2003
Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in ratsLinda A Parker, Raphael Mechoulam
Dialogues in Clinical Neuroscience|February 22, 2008
Cannabinoids in health and diseaseNatalya M Kogan, Raphael Mechoulam
Annual Review of Psychology|July 19, 2012
The endocannabinoid system and the brainRaphael Mechoulam, Linda A Parker
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2005
Toward an anandamide transporterRaphael Mechoulam, Dale G Deutsch
Pharmacology & Therapeutics|August 17, 2002
Tetrahydrocannabinol and endocannabinoids in feeding and appetiteElliot M Berry, Raphael Mechoulam
Pageof 19